ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding ClearPoint Neuro, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 50 | −13 |
| Shares | 4.76M | 3.11K | 3.48M | −1.27M (−26.7%) |
| Value | $49.5M | $32.0K | $45.4M | −$4.02M (−8.1%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 190,546 | $2.49M | 0.00% |
| Essex Investment Management Co LLC | 105,590 | $1.38M | 0.22% |
| Ergoteles LLC | 91,500 | $1.19M | 0.04% |
| EAM Investors, LLC | 87,883 | $1.15M | 0.28% |
| Pinz Capital Management, LP | 51,240 | $669.0K | 0.46% |
| Citadel Advisors LLC | 35,117 | $458.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 29,444 | $384.0K | 0.00% |
| Qube Research & Technologies Ltd | 11,781 | $154.0K | 0.00% |
| Castle Wealth Management LLC | 2,500 | $33.0K | 0.02% |
| Nisa Investment Advisors, LLC | 2,100 | $27.0K | 0.00% |
| Optimum Investment Advisors | 1,000 | $13.0K | 0.01% |
| Total Clarity Wealth Management, Inc. | 750 | $10.0K | 0.01% |
| Harbour Investments, Inc. | 125 | $2.00K | 0.00% |
| Fairfield, Bush & Co. | 134 | $2.00K | 0.00% |
| Credit Suisse AG | 10 | $0 | 0.00% |
Sold out (28)
Institutions that held ClearPoint Neuro, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (1)
Institutions that held ClearPoint Neuro, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 3,111 | $32.0K |